Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cryoport, Inc. Director's Dealing 2024

Dec 5, 2024

32876_dirs_2024-12-04_157648de-7c98-4d8e-9fdf-dc66b8446481.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cryoport, Inc. (CYRX)
CIK: 0001124524
Period of Report: 2024-12-02

Reporting Person: Mandalam Ramkumar (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-12-02 Common Stock M 10834 $4.8 Acquired 66866 Direct
2024-12-02 Common Stock S 7369 $7.4607 Disposed 59497 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-12-02 Stock Option (right to buy) $4.80 M 10834 Disposed 2024-12-18 Common Stock (10834) Direct

Footnotes

F1: The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.10 to $7.81, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The options vested ratably over forty-eight months on the 18th day of each month beginning on 1/18/2015.